These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20876772)

  • 61. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall.
    Galkina E; Harry BL; Ludwig A; Liehn EA; Sanders JM; Bruce A; Weber C; Ley K
    Circulation; 2007 Oct; 116(16):1801-11. PubMed ID: 17909108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
    Tissot AC; Spohn G; Jennings GT; Shamshiev A; Kurrer MO; Windak R; Meier M; Viesti M; Hersberger M; Kündig TM; Ricci R; Bachmann MF
    Eur J Immunol; 2013 Mar; 43(3):716-22. PubMed ID: 23254454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduced T-dependent humoral immunity in CD20-deficient mice.
    Morsy DE; Sanyal R; Zaiss AK; Deo R; Muruve DA; Deans JP
    J Immunol; 2013 Sep; 191(6):3112-8. PubMed ID: 23966626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of natural killer T cell activation on the initiation of atherosclerosis.
    van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J
    Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunotherapy for atherosclerosis by targeting pro-inflammatory T cells.
    Khan A; Ley K
    Cell Res; 2024 Jul; 34(7):467-468. PubMed ID: 38565655
    [No Abstract]   [Full Text] [Related]  

  • 68. In-depth B cell immunophenotyping to monitor response to anti-CD20 therapy in CNS autoimmunity.
    Su E; Wetzel NS; Oak J; Kipp L; Han MH
    Mult Scler Relat Disord; 2020 Nov; 46():102594. PubMed ID: 33296989
    [No Abstract]   [Full Text] [Related]  

  • 69. Atherosclerosis.
    Kobiyama K; Ley K
    Circ Res; 2018 Oct; 123(10):1118-1120. PubMed ID: 30359201
    [No Abstract]   [Full Text] [Related]  

  • 70. Inflammation: Targeting inflammatory pathways to treat atherosclerosis and cancer.
    Huynh K
    Nat Rev Cardiol; 2017 Nov; 14(11):629. PubMed ID: 28905870
    [No Abstract]   [Full Text] [Related]  

  • 71. Working together to fighting the bad guys.
    Wettstadt S
    Microlife; 2023; 4():uqad022. PubMed ID: 37223724
    [No Abstract]   [Full Text] [Related]  

  • 72. Inflammation and autoimmunity in atherosclerosis.
    Surma S; Filipiak KJ
    Reumatologia; 2022; 60(1):1-3. PubMed ID: 35645416
    [No Abstract]   [Full Text] [Related]  

  • 73. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
    Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
    J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of T and B cells in atherosclerosis: potential clinical implications.
    Dumitriu IE; Kaski JC
    Curr Pharm Des; 2011 Dec; 17(37):4159-71. PubMed ID: 22204376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The B cell in atherosclerosis: teaming up with the bad guys?
    Nilsson J; Fredrikson GN
    Clin Chem; 2010 Dec; 56(12):1789-91. PubMed ID: 20876772
    [No Abstract]   [Full Text] [Related]  

  • 78. B cell depletion reduces the development of atherosclerosis in mice.
    Ait-Oufella H; Herbin O; Bouaziz JD; Binder CJ; Uyttenhove C; Laurans L; Taleb S; Van Vré E; Esposito B; Vilar J; Sirvent J; Van Snick J; Tedgui A; Tedder TF; Mallat Z
    J Exp Med; 2010 Aug; 207(8):1579-87. PubMed ID: 20603314
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.